Investment
Features
FeesSafety
Academy
More
Pluang+

Compare H World Group Limited American Depositary Shares (HTHT) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance

H World Group Limited American Depositary SharesTrade
Oruka Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

H World Group Limited American Depositary Shares vs Oruka Therapeutics Inc. Common Stock — how do they compare? H World Group Limited American Depositary Shares trades at $44.25 (market cap $14.16B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B). The key difference: H World Group Limited American Depositary Shares is far larger — about 2.7× Oruka Therapeutics Inc. Common Stock's market cap, and H World Group Limited American Depositary Shares pays a 4.91% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold H World Group Limited American Depositary Shares for 6 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.

HTHTORKA
Market Cap
$14.16B$5.18B
Volume
1,525,108490,798
Sector
Consumer CyclicalHealth
52-Week High
$56.06$113.08
52-Week Low
$36.99$26.19
Typical Hold Time
6 Days0 Days
Enterprise Value
$16.95B$4.31B
Dividend Yield
4.91%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

H World Group Limited American Depositary Shares

HTHT trades at $44.17, down 0.85% on the day, with a bullish technical signal supported by moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $0.78 exceeding the $0.74 estimate. Revenue for 2025 was $25.31 billion, with a net income margin of 18.93% and robust ROE of 38.39%. Positive news highlights the asset-light model's margin improvement and a recent CNY bond offering.

The outlook remains positive with a consensus price target of $50.56, implying 14.5% upside, supported by earnings momentum and operational efficiency. Key risks include market saturation in China and reliance on domestic growth. Analyst sentiment is bullish with 11 buy ratings out of 19, though valuation multiples like a P/E of 31.46 warrant monitoring.

Oruka Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HTHT

No sentiment data available yet.

ORKA
100% Buy0% Sell
Avg holding period · 0 Days

About H World Group Limited American Depositary Shares

H World Group operates hotels through leased and owned, managed franchise, and franchise models. Its brands include HanTing, JI Hotel, Orange Hotel, and Steigenberger Hotels & Resorts.

Read more on HTHT →

About Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.

Read more on ORKA →